Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Also known as paracetamol 4.8% paediatric oral suspension
paracetamol 4.8% paediatric · 1 trial · 2 indications
| Name | Type | Description |
|---|---|---|
| paracetamol 4.8% paediatric oral suspension | DRUG | - |
The following information on clinical trials is provided for information purposes only to allow patients and physicians to have an initial discussion about the trial. This information is not intended to be complete information about the trial, to contain all considerations that may be relevant to po...
Paracetamol 4.8% paediatric is an oral suspension formulation of paracetamol developed by Sanofi for use in children. It is being studied for fever, with the trial also listing pain as a condition. The product is a small molecule medicine given as a paediatric oral suspension.
Paracetamol 4.8% paediatric is used for fever in children, and the clinical trial for this formulation also listed pain as a condition. It is an oral suspension, a liquid dose form intended for paediatric patients, including very young infants based on the trial's minimum age of one day.
Sanofi develops paracetamol 4.8% paediatric. Sanofi trades under the ticker SNY. The company is the sponsor behind the clinical development of this paediatric oral suspension formulation.
Paracetamol 4.8% paediatric is in Phase 3 development. It is an investigational formulation and is not described as approved. One Phase 3 trial has been completed, and no trials for this formulation are currently active.
Paracetamol 4.8% paediatric has been studied in one completed Phase 3 trial, NCT00434681, titled Paracetamol Oral Paediatric Suspension at 4.8%: Study of Acceptability and Safety. The trial enrolled 48 participants in France, included both sexes, and accepted patients from one day of age.
Yes, paracetamol 4.8% paediatric is also known as paracetamol 4.8% paediatric oral suspension. Both names refer to the same Sanofi product, a liquid oral suspension formulation of paracetamol at a 4.8% concentration developed for paediatric use in fever.